Brontictuzumab

Chemical compound From Wikipedia, the free encyclopedia

Brontictuzumab (INN; development code OMP-52M51) is a humanized monoclonal antibody designed for the treatment of cancer.[1][2]

TypeWhole antibody
SourceHumanized (from mouse)
TargetNotch 1
Other namesOMP-52M51
Quick facts Monoclonal antibody, Type ...
Brontictuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetNotch 1
Clinical data
Other namesOMP-52M51
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6392H9862N1980O1710S50
Molar mass143410.36 g·mol−1
Close

It blocks the NOTCH1 receptor.[3]

This drug was developed by OncoMed Pharmaceuticals.

References

Related Articles

Wikiwand AI